165 related articles for article (PubMed ID: 35793862)
1. A multimodal prehabilitation program for the reduction of post-operative complications after surgery in advanced ovarian cancer under an ERAS pathway: a randomized multicenter trial (SOPHIE).
Díaz-Feijoo B; Agusti N; Sebio R; Sisó M; Carreras-Dieguez N; Domingo S; Díaz-Cambronero O; Torne A; Martinez-Palli G; Arguís MJ
Int J Gynecol Cancer; 2022 Jul; ():. PubMed ID: 35793862
[TBL] [Abstract][Full Text] [Related]
2. The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design.
Inci MG; Sehouli J; Schnura E; Lee M; Roll S; Reinhold T; Klews J; Kaufner L; Niggemann P; Groeben H; Toelkes J; Reisshauer A; Liebl M; Daehnert E; Zimmermann M; Knappe-Drzikova B; Rolker S; Nunier B; Algharably E; Pirmorady Sehouli A; Zwantleitner L; Krull A; Heitz F; Ataseven B; Chekerov R; Harter P; Schneider S
Int J Gynecol Cancer; 2023 Aug; 33(8):1304-1309. PubMed ID: 37208019
[TBL] [Abstract][Full Text] [Related]
3. PROPER-PRehabilitatiOn Plus Enhanced Recovery after surgery versus enhanced recovery after surgery in gynecologic oncology: a randomized clinical trial.
Lopes A; Yamada AMTD; Cardenas TC; Carvalho JN; Oliveira EA; Silva MERD; Andrade JFM; de Souza Neto E; Barros LADR; Costa RLR
Int J Gynecol Cancer; 2022 Feb; 32(2):195-197. PubMed ID: 34750197
[TBL] [Abstract][Full Text] [Related]
4. Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study.
Miralpeix E; Sole-Sedeno JM; Rodriguez-Cosmen C; Taus A; Muns MD; Fabregó B; Mancebo G
World J Surg Oncol; 2022 Feb; 20(1):46. PubMed ID: 35197061
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of a Multimodal Prehabilitation Programme in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer: A Pilot Study.
Diaz-Feijoo B; Agusti-Garcia N; Sebio R; López-Hernández A; Sisó M; Glickman A; Carreras-Dieguez N; Fuste P; Marina T; Martínez-Egea J; Aguilera L; Perdomo J; Pelaez A; López-Baamonde M; Navarro-Ripoll R; Gimeno E; Campero B; Torné A; Martinez-Palli G; Arguis MJ
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406407
[TBL] [Abstract][Full Text] [Related]
6. Multimodal prehabilitation as strategy for reduction of postoperative complications after cardiac surgery: a randomised controlled trial protocol.
Coca-Martinez M; Lopez-Hernandez A; Montane-Muntane M; Arguis MJ; Gimeno-Santos E; Navarro-Ripoll R; Perdomo J; Lopez-Baamonde M; Rios J; Moises J; Sanz de la Garza M; Sandoval E; Romano B; Sebio R; Dana F; Martinez-Palli G
BMJ Open; 2020 Dec; 10(12):e039885. PubMed ID: 33371022
[TBL] [Abstract][Full Text] [Related]
7. Effect of Multimodal Prehabilitation on Reducing Postoperative Complications and Enhancing Functional Capacity Following Colorectal Cancer Surgery: The PREHAB Randomized Clinical Trial.
Molenaar CJL; Minnella EM; Coca-Martinez M; Ten Cate DWG; Regis M; Awasthi R; Martínez-Palli G; López-Baamonde M; Sebio-Garcia R; Feo CV; van Rooijen SJ; Schreinemakers JMJ; Bojesen RD; Gögenur I; van den Heuvel ER; Carli F; Slooter GD;
JAMA Surg; 2023 Jun; 158(6):572-581. PubMed ID: 36988937
[TBL] [Abstract][Full Text] [Related]
8. Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation.
van Rooijen S; Carli F; Dalton S; Thomas G; Bojesen R; Le Guen M; Barizien N; Awasthi R; Minnella E; Beijer S; Martínez-Palli G; van Lieshout R; Gögenur I; Feo C; Johansen C; Scheede-Bergdahl C; Roumen R; Schep G; Slooter G
BMC Cancer; 2019 Jan; 19(1):98. PubMed ID: 30670009
[TBL] [Abstract][Full Text] [Related]
9. PRehabIlitatiOn with pReoperatIve exercise and educaTion for patients undergoing major abdominal cancer surgerY: protocol for a multicentre randomised controlled TRIAL (PRIORITY TRIAL).
Steffens D; Young J; Riedel B; Morton R; Denehy L; Heriot A; Koh C; Li Q; Bauman A; Sandroussi C; Ismail H; Dieng M; Ansari N; Pillinger N; O'Shannassy S; McKeown S; Cunningham D; Sheehan K; Iori G; Bartyn J; Solomon M
BMC Cancer; 2022 Apr; 22(1):443. PubMed ID: 35459100
[TBL] [Abstract][Full Text] [Related]
10. The protocol for the prehabilitation for thoracic surgery study: a randomized pragmatic trial comparing a short home-based multimodal program to aerobic training in patients undergoing video-assisted thoracoscopic surgery lobectomy.
Liu Y; Liu Z; Zhang Y; Cui Y; Pei L; Huang Y
Trials; 2023 Mar; 24(1):194. PubMed ID: 36922827
[TBL] [Abstract][Full Text] [Related]
11. The Wessex Fit-4-Cancer Surgery Trial (WesFit): a protocol for a factorial-design, pragmatic randomised-controlled trial investigating the effects of a multi-modal prehabilitation programme in patients undergoing elective major intra-cavity cancer surgery.
West M; Bates A; Grimmett C; Allen C; Green R; Hawkins L; Moyses H; Leggett S; Z H Levett D; Rickard S; Varkonyi-Sepp J; Williams F; Wootton S; Hayes M; P W Grocott M; Jack S
F1000Res; 2021; 10():952. PubMed ID: 36247802
[No Abstract] [Full Text] [Related]
12. Effect of Multimodal Prehabilitation vs Postoperative Rehabilitation on 30-Day Postoperative Complications for Frail Patients Undergoing Resection of Colorectal Cancer: A Randomized Clinical Trial.
Carli F; Bousquet-Dion G; Awasthi R; Elsherbini N; Liberman S; Boutros M; Stein B; Charlebois P; Ghitulescu G; Morin N; Jagoe T; Scheede-Bergdahl C; Minnella EM; Fiore JF
JAMA Surg; 2020 Mar; 155(3):233-242. PubMed ID: 31968063
[TBL] [Abstract][Full Text] [Related]
13. Prehabilitation programs and ERAS protocols in gynecological oncology: a comprehensive review.
Schneider S; Armbrust R; Spies C; du Bois A; Sehouli J
Arch Gynecol Obstet; 2020 Feb; 301(2):315-326. PubMed ID: 31616986
[TBL] [Abstract][Full Text] [Related]
14. Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative).
Gaba F; Ash K; Blyuss O; Bizzarri N; Kamfwa P; Ramirez PT; Kotsopoulos IC; Chandrasekaran D; Gomes N; Butler J; Nobbenhuis M; Ind T; Heath O; Barton D; Jeyarajah A; Brockbank E; Lawrence A; Dilley J; Manchanda R; Phadnis S; Soar GO
Int J Gynecol Cancer; 2022 Dec; 32(12):1606-1610. PubMed ID: 36379595
[TBL] [Abstract][Full Text] [Related]
15. TRAINING-Ovary 01 (connecTed pRehabiliAtIoN pelvIc caNcer surGery): multicenter randomized study comparing neoadjuvant chemotherapy for patients managed for ovarian cancer with or without a connected pre-habilitation program.
Lambaudie E; Bannier/Braticevic C; Villaron/Goetgheluck C; Zemmour C; Boher JM; Ben Soussan P; Pakradouni J; Brun C; Lopez Almeida L; Marino P
Int J Gynecol Cancer; 2021 Jun; 31(6):920-924. PubMed ID: 33262113
[TBL] [Abstract][Full Text] [Related]
16. Multimodal prehabilitation to improve the clinical outcomes of frail elderly patients with gastric cancer: a study protocol for a multicentre randomised controlled trial (GISSG
Sun Y; Tian Y; Cao S; Li L; Yu W; Ding Y; Wang X; Kong Y; Wang X; Wang H; Hui X; Qu J; Wang H; Duan Q; Yang D; Zhang H; Zhou S; Liu X; Li Z; Meng C; Kehlet H; Zhou Y
BMJ Open; 2023 Oct; 13(10):e071714. PubMed ID: 37816552
[TBL] [Abstract][Full Text] [Related]
17. Role and impact of multimodal prehabilitation for gynecologic oncology patients in an Enhanced Recovery After Surgery (ERAS) program.
Miralpeix E; Mancebo G; Gayete S; Corcoy M; Solé-Sedeño JM
Int J Gynecol Cancer; 2019 Oct; 29(8):1235-1243. PubMed ID: 31473663
[TBL] [Abstract][Full Text] [Related]
18. Assessing the Value of Prehabilitation in Patients Undergoing Colorectal Surgery According to the Enhanced Recovery After Surgery (ERAS) Pathway for the Improvement of Postoperative Outcomes: Protocol for a Randomized Controlled Trial.
Merki-Künzli C; Kerstan-Huber M; Switalla D; Gisi D; Raptis DA; Greco N; Mungo G; Wirz M; Gloor S; Misirlic M; Breitenstein S; Tschuor C
JMIR Res Protoc; 2017 Oct; 6(10):e199. PubMed ID: 29079551
[TBL] [Abstract][Full Text] [Related]
19. Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.
Koole S; van Stein R; Sikorska K; Barton D; Perrin L; Brennan D; Zivanovic O; Mosgaard BJ; Fagotti A; Colombo PE; Sonke G; Driel WJV;
Int J Gynecol Cancer; 2020 Jun; 30(6):888-892. PubMed ID: 32205449
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and acceptability of PrE-operative Physical Activity to improve patient outcomes After major cancer surgery: study protocol for a pilot randomised controlled trial (PEPA Trial).
Steffens D; Young J; Beckenkamp PR; Ratcliffe J; Rubie F; Ansari N; Pillinger N; Solomon M
Trials; 2018 Feb; 19(1):112. PubMed ID: 29452599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
